Meeting
2022 ASCO Genitourinary Cancers Symposium
Practice patterns in the management of metastatic castration-sensitive prostate cancer: A single-center survey-based study.
Authors
Eric Lu
Division of Hematology-Oncology, University of California, Los Angeles, Los Angeles, CA
Eric Lu , Xiaoyan Wang , John Shen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Quality of Care/Quality Improvement and Real-World Evidence
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 45)
DOI
10.1200/JCO.2022.40.6_suppl.045
Abstract #
45
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Real-world first-line (1L) treatment patterns in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) in a U.S. health insurance database.
First Author: Umang Swami
Poster
2021 ASCO Annual Meeting
Real-world treatment patterns among patients diagnosed with metastatic castration-sensitive prostate cancer (mCSPC) in community oncology settings.
First Author: Daniel J. George
Poster
2024 ASCO Genitourinary Cancers Symposium
Clinical and patient factors associated with treatment intensification for metastatic castration-sensitive prostate cancer.
First Author: Sreevalsa Appukkuttan
Poster
2024 ASCO Genitourinary Cancers Symposium
A phase IIa study of sequential ("first strike, second strike") therapies, modeled on evolutionary dynamics of anthropocene extinctions, for high-risk metastatic castration-sensitive prostate cancer.
First Author: Jingsong Zhang